-

Nu-Tek BioSciences Drives Pharma Innovation with Animal-Free Ingredients at CPhI Global 2025

  • Nu-Tek BioSciences will attend CPhI Global from October 28-30, 2025, in Frankfurt, Germany.
  • The company provides 100% animal-free peptones and specialty yeast extracts essential for biomanufacturing.
  • Nu-Tek's complex materials are crucial for accelerating pharmaceutical innovation and development pipelines.

MINNETONKA, Minn.--(BUSINESS WIRE)--Nu-Tek BioSciences, the market leader in 100% animal-free peptones and specialty yeast extracts, today announced its participation at CPhI Global, the world's largest pharmaceutical showcase. The conference will take place from October 28-30, 2025, at Messe Frankfurt in Frankfurt, Germany. Biomanufacturers and pharmaceutical innovators are invited to connect with Nu-Tek BioSciences to discover how their critical ingredients can significantly enhance and streamline the drug development pipeline.

Nu-Tek's animal-free peptones and yeast extracts are critical for the production of pharmaceutical products world-wide, making CPHI an important connecting point for customers.

Share

As the leader in animal-free peptones and yeast extracts, Nu-Tek’s product portfolio provides scalable, sustainable materials critical to cell culture and industrial fermentation processes. Each product is manufactured in the company’s US-based state-of-the-art, purpose-built facility, with options for ultrafiltration, Organic, HALAL, and Kosher designations.

"CPhI Global provides an unparalleled opportunity to engage with the international pharmaceutical community and demonstrate our role in driving innovation," said Tom Yezzi, CEO for Nu-Tek BioSciences. "Our 100% animal-free products are designed to meet the evolving demands of modern biomanufacturing, offering superior performance and helping our partners to optimize their research, development, and production. We are eager to connect with leaders during the show to illustrate how our solutions and focus on variability reduction can be leveraged at every stage of the pharma pipeline, supporting our customers’ path to creating life-changing medicines."

Attendees are encouraged to meet the Nu-Tek BioSciences team, explore the company’s comprehensive range of animal-free products, and discuss specific application needs, such as the company’s novel Variability Reduction Program. The Nu-Tek team schedule can be found through https://tinyurl.com/mwjrxynh.

About Nu-Tek BioSciences:

Nu-Tek BioSciences is a market leader in the development and manufacturing of high-quality, 100% animal-origin-free (AOF) peptones and protein hydrolysates. Headquartered in Minnetonka, Minnesota, the company operates a state-of-the-art, purpose-built manufacturing facility dedicated to producing superior raw materials for the biopharmaceutical industry. Nu-Tek's innovative solutions are essential for cell culture and microbial fermentation, supporting the production of vaccines, therapeutics, and other vital biologics.

Contacts

Media Contact:
Courtney Jones
Director of Commercial Development
cjones@nu-tekbioscience.com
+1(952) 936.3614
www.nu-tekbiosciences.com

Nu-Tek BioSciences


Release Summary
Announcing Nu-Tek BioScience's attendance of CPHI Global in Frankfurt, Germany.
Release Versions

Contacts

Media Contact:
Courtney Jones
Director of Commercial Development
cjones@nu-tekbioscience.com
+1(952) 936.3614
www.nu-tekbiosciences.com

Social Media Profiles
More News From Nu-Tek BioSciences

Nu-Tek BioSciences Highlights Animal-Free Ingredient Advantages at SIMB RAFT 2025

MINNETONKA, Minn.--(BUSINESS WIRE)--Nu-Tek Hosts Booth, Animal-Free Products for Industrial Fermentation at SIMB RAFT 2025....

Nu-Tek BioSciences Awarded EcoVadis Status for Second Year, Reinforcing Commitment to Sustainable Innovation

MINNETONKA, Minn.--(BUSINESS WIRE)--Nu-Tek BioSciences, the market leader in plant-based peptones and yeast extracts for the biopharmaceutical industry, has been awarded the Bronze designation 2025 by EcoVadis for the second year. This distinction places Nu-Tek among the top 35% of companies evaluated by EcoVadis and underscores its ongoing commitment to environmental stewardship and responsible business practices. EcoVadis assesses companies across key sustainability criteria, including enviro...

Nu-Tek BioSciences Unveils Collaborative Program to Boost Customer Cell Culture & Fermentation Efficiency

MINNETONKA, Minn.--(BUSINESS WIRE)--Nu-Tek Announces the Launch of Their Variability Reduction Program For Pharma and Biotech Production Optimization....
Back to Newsroom